Ahmedabad: Anthem Biosciences Limited (the “Company”) proposes to open an initial public offering (“Offer”) of its equity shares of face value of ₹2 each (“Equity Shares”) on Monday, July 14, 2025. The Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, being Friday, July 11, 2025. The Bid/ Offer Closing Date is Wednesday, July 16, 2025, the company announced Thursday.

As per the company, the Price Band of the Offer has been fixed from ₹ 540 per Equity Share to ₹ 570 per Equity Share. Bids can be made for a minimum of 26 Equity Shares and multiples of 26 Equity Shares thereafter.

“The Initial Public Offering comprises an Offer for Sale of Equity Shares aggregating up ₹33,950 million by the Selling Shareholders comprising of Equity Shares aggregating up to ₹3,500 million by Ganesh Sambasivam; Equity Shares aggregating up to ₹3,500 million by K Ravindra Chandrappa; Equity Shares aggregating up to ₹ 13,250 million by Viridity Tone LLP; Equity Shares aggregating up to ₹ 3,200 million each by Portsmouth Technologies LLC, Malay J Barua, Rupesh N Kinekar and Satish Sharma; Equity Shares aggregating up to ₹ 800 million by Prakash Kariabettan and Equity Shares aggregating up to ₹ 100 million by K Ramakrishnan.”

The Equity Shares of the Company are proposed to be listed on BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”) (BSE and NSE together, the “Stock Exchanges”). JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited are the Book Running Lead Managers (“BRLMs”) to the Offer, the company further said.